Antipneumococcal Activity of LBM415, a New Peptide Diformylase Inhibitor, Compared with Those of Other Agents

The MICs of LBM415, a new peptide diformylase inhibitor, were evaluated and ranged from 0.03 to 4.0 μg/ml for 300 pneumococci, irrespective of their β-lactam, macrolide, and quinolone susceptibilities. By comparison, vancomycin, teicoplanin, linezolid, and quinupristin-dalfopristin were also active,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Antimicrob Agents Chemother
Main Authors: Ednie, Lois M., Pankuch, Glenn, Appelbaum, Peter C.
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology (ASM) 2004
Fag:
Susceptibility
Online adgang:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC521909/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15388472/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.10.4027-4032.2004
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker